本頁面由Tiger Trade Technology Pte. Ltd.提供服務

德康醫療

83.32
-0.0100-0.01%
成交量:10.60萬
成交額:883.66萬
市值:310.74億
市盈率:32.67
高:83.75
開:83.46
低:82.87
收:83.33
52周最高:92.59
52周最低:56.72
股本:3.73億
流通股本:3.72億
量比:0.74
換手率:0.03%
股息:- -
股息率:- -
每股收益(TTM):2.55
每股收益(LYR):2.09
淨資產收益率:37.67%
總資產收益率:11.13%
市淨率:12.26
市盈率(LYR):39.88

資料載入中...

2026/07/20

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/28

重要事件披露

Form 8-K - Current report
2026/05/22

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/15

重要事件披露

Form 8-K - Current report
2026/05/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/30

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/04/30

重要事件披露

Form 8-K - Current report
2026/04/29

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/29

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/17

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/03

重要事件披露

Form 8-K - Current report
2026/02/26

重要事件披露

Form 8-K - Current report